Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 357

1.

Evolution of Business Models in Regenerative Medicine: Effects of a Disruptive Innovation on the Innovation Ecosystem.

Banda G, Tait J, Mittra J.

Clin Ther. 2018 Jul 14. pii: S0149-2918(18)30254-6. doi: 10.1016/j.clinthera.2018.06.003. [Epub ahead of print]

PMID:
30017170
2.

Influence of Sequential vs. Simultaneous Dual-Task Exercise Training on Cognitive Function in Older Adults.

Tait JL, Duckham RL, Milte CM, Main LC, Daly RM.

Front Aging Neurosci. 2017 Nov 7;9:368. doi: 10.3389/fnagi.2017.00368. eCollection 2017. Review.

3.

A transatlantic perspective on 20 emerging issues in biological engineering.

Wintle BC, Boehm CR, Rhodes C, Molloy JC, Millett P, Adam L, Breitling R, Carlson R, Casagrande R, Dando M, Doubleday R, Drexler E, Edwards B, Ellis T, Evans NG, Hammond R, Haseloff J, Kahl L, Kuiken T, Lichman BR, Matthewman CA, Napier JA, ÓhÉigeartaigh SS, Patron NJ, Perello E, Shapira P, Tait J, Takano E, Sutherland WJ.

Elife. 2017 Nov 14;6. pii: e30247. doi: 10.7554/eLife.30247.

4.

A quasi-experimental evaluation of dried blood spot testing through community pharmacies in the Tayside region of Scotland.

Radley A, Melville K, Tait J, Stephens B, Evans JMM, Dillon JF.

Frontline Gastroenterol. 2017 Jul;8(3):221-228. doi: 10.1136/flgastro-2016-100776. Epub 2017 Jan 6.

5.

DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy.

Radley A, Tait J, Dillon JF.

Int J Drug Policy. 2017 Sep;47:126-136. doi: 10.1016/j.drugpo.2017.05.042. Epub 2017 Jun 21.

PMID:
28647161
6.

Multidisciplinary managed care networks-Life-saving interventions for hepatitis C patients.

Tait JM, Wang H, Stephens BP, Miller M, McIntyre PG, Cleary S, Dillon JF.

J Viral Hepat. 2017 Mar;24(3):207-215. doi: 10.1111/jvh.12633. Epub 2016 Nov 7.

PMID:
28127941
7.

Osmotic versus adrenergic control of ion transport by ionocytes of Fundulus heteroclitus in the cold.

Tait JC, Mercer EW, Gerber L, Robertson GN, Marshall WS.

Comp Biochem Physiol A Mol Integr Physiol. 2017 Jan;203:255-261. doi: 10.1016/j.cbpa.2016.10.003. Epub 2016 Oct 13.

PMID:
27746134
8.

Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair Genes.

Cohen SA, Turner EH, Beightol MB, Jacobson A, Gooley TA, Salipante SJ, Haraldsdottir S, Smith C, Scroggins S, Tait JF, Grady WM, Lin EH, Cohn DE, Goodfellow PJ, Arnold MW, de la Chapelle A, Pearlman R, Hampel H, Pritchard CC.

Gastroenterology. 2016 Sep;151(3):440-447.e1. doi: 10.1053/j.gastro.2016.06.004. Epub 2016 Jun 11.

9.

The acute physiological stress response to an emergency alarm and mobilization during the day and at night.

Hall SJ, Aisbett B, Tait JL, Turner AI, Ferguson SA, Main LC.

Noise Health. 2016 May-Jun;18(82):150-6. doi: 10.4103/1463-1741.181998.

10.

Salinity Preference in the Estuarine Teleost Fish Mummichog (Fundulus heteroclitus): Halocline Behavior.

Marshall WS, Tait JC, Mercer EW.

Physiol Biochem Zool. 2016 May-Jun;89(3):225-32. doi: 10.1086/686037. Epub 2016 Mar 7.

PMID:
27153132
11.

Improving performance of multigene panels for genomic analysis of cancer predisposition.

Shirts BH, Casadei S, Jacobson AL, Lee MK, Gulsuner S, Bennett RL, Miller M, Hall SA, Hampel H, Hisama FM, Naylor LV, Goetsch C, Leppig K, Tait JF, Scroggins SM, Turner EH, Livingston R, Salipante SJ, King MC, Walsh T, Pritchard CC.

Genet Med. 2016 Oct;18(10):974-81. doi: 10.1038/gim.2015.212. Epub 2016 Feb 4.

PMID:
26845104
12.

Insights into the nanoscale lateral and vertical phase separation in organic bulk heterojunctions via scanning probe microscopy.

Chintala R, Tait JG, Eyben P, Voroshazi E, Surana S, Fleischmann C, Conard T, Vandervorst W.

Nanoscale. 2016 Feb 14;8(6):3629-37. doi: 10.1039/c5nr08765a.

PMID:
26810305
13.

Interfacial Depletion Regions: Beyond the Space Charge Limit in Thick Bulk Heterojunctions.

Tait JG, Paetzold UW, Cheyns D, Turbiez M, Heremans P, Rand BP.

ACS Appl Mater Interfaces. 2016 Jan 27;8(3):2211-9. doi: 10.1021/acsami.5b10891. Epub 2016 Jan 14.

PMID:
26690662
14.

NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys.

Kurzrock R, Colevas AD, Olszanski A, Akerley W, Arteaga CL, Carson WE 3rd, Clark JW, DiPersio JF, Ettinger DS, Morgan RJ Jr, Schwartzberg LS, Venook AP, Gocke CD, Tait J, Stewart FM.

J Natl Compr Canc Netw. 2015 Nov;13(11):1337-46.

PMID:
26553764
15.

DNA Yield From Tissue Samples in Surgical Pathology and Minimum Tissue Requirements for Molecular Testing.

Austin MC, Smith C, Pritchard CC, Tait JF.

Arch Pathol Lab Med. 2016 Feb;140(2):130-3. doi: 10.5858/arpa.2015-0082-OA. Epub 2015 Jun 22.

PMID:
26098132
16.

Effectiveness of dual-task functional power training for preventing falls in older people: study protocol for a cluster randomised controlled trial.

Daly RM, Duckham RL, Tait JL, Rantalainen T, Nowson CA, Taaffe DR, Sanders K, Hill KD, Kidgell DJ, Busija L.

Trials. 2015 Mar 27;16:120. doi: 10.1186/s13063-015-0652-y.

17.

Absorptive carbon nanotube electrodes: consequences of optical interference loss in thin film solar cells.

Tait JG, De Volder MF, Cheyns D, Heremans P, Rand BP.

Nanoscale. 2015 Apr 28;7(16):7259-66. doi: 10.1039/c5nr01119a.

PMID:
25811493
18.

Are flying-foxes coming to town? Urbanisation of the spectacled flying-fox (Pteropus conspicillatus) in Australia.

Tait J, Perotto-Baldivieso HL, McKeown A, Westcott DA.

PLoS One. 2014 Oct 8;9(10):e109810. doi: 10.1371/journal.pone.0109810. eCollection 2014.

19.

Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer.

Pritchard CC, Morrissey C, Kumar A, Zhang X, Smith C, Coleman I, Salipante SJ, Milbank J, Yu M, Grady WM, Tait JF, Corey E, Vessella RL, Walsh T, Shendure J, Nelson PS.

Nat Commun. 2014 Sep 25;5:4988. doi: 10.1038/ncomms5988.

20.

Identifying viable regulatory and innovation pathways for regenerative medicine: a case study of cultured red blood cells.

Mittra J, Tait J, Mastroeni M, Turner ML, Mountford JC, Bruce K.

N Biotechnol. 2015 Jan 25;32(1):180-90. doi: 10.1016/j.nbt.2014.07.008. Epub 2014 Aug 2.

21.

Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy.

Miller MH, Agarwal K, Austin A, Brown A, Barclay ST, Dundas P, Dusheiko GM, Foster GR, Fox R, Hayes PC, Leen C, Millson C, Ryder SD, Tait J, Ustianowski A, Dillon JF; British Viral Hepatitis group; British Society of Gastroenterology Liver Committee; British Association for the Study of Liver; Scottish Society of Gastroenterology; Scottish Viral Hepatitis group; Scottish Viral Hepatitis Nurses group.

Aliment Pharmacol Ther. 2014 Jun;39(12):1363-75. doi: 10.1111/apt.12764. Epub 2014 Apr 22.

22.

Preventability of severe acute maternal morbidity.

Lawton B, MacDonald EJ, Brown SA, Wilson L, Stanley J, Tait JD, Dinsdale RA, Coles CL, Geller SE.

Am J Obstet Gynecol. 2014 Jun;210(6):557.e1-6. doi: 10.1016/j.ajog.2013.12.032. Epub 2014 Feb 6.

PMID:
24508582
23.

Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens.

Pritchard CC, Salipante SJ, Koehler K, Smith C, Scroggins S, Wood B, Wu D, Lee MK, Dintzis S, Adey A, Liu Y, Eaton KD, Martins R, Stricker K, Margolin KA, Hoffman N, Churpek JE, Tait JF, King MC, Walsh T.

J Mol Diagn. 2014 Jan;16(1):56-67. doi: 10.1016/j.jmoldx.2013.08.004. Epub 2013 Nov 2.

24.

Efficacy of mifepristone for cervical priming for second-trimester surgical termination of pregnancy.

Searle L, Tait J, Langdana F, Maharaj D.

Int J Gynaecol Obstet. 2014 Jan;124(1):38-41. doi: 10.1016/j.ijgo.2013.05.029. Epub 2013 Sep 26.

PMID:
24135291
25.

Dry blood spot testing for hepatitis C in people who injected drugs: reaching the populations other tests cannot reach.

Tait JM, Stephens BP, McIntyre PG, Evans M, Dillon JF.

Frontline Gastroenterol. 2013 Oct;4(4):255-262. doi: 10.1136/flgastro-2013-100308. Epub 2013 May 11.

26.

Towards a more open debate about values in decision-making on agricultural biotechnology.

Devos Y, Sanvido O, Tait J, Raybould A.

Transgenic Res. 2014 Dec;23(6):933-43. doi: 10.1007/s11248-013-9754-z. Epub 2013 Sep 13.

PMID:
24030046
27.

Novel GM animal technologies and their governance.

Bruce A, Castle D, Gibbs C, Tait J, Whitelaw CB.

Transgenic Res. 2013 Aug;22(4):681-95. doi: 10.1007/s11248-013-9724-5. Epub 2013 Jun 19. Review.

PMID:
23780762
28.

Plasma processing conditions substantially influence circulating microRNA biomarker levels.

Cheng HH, Yi HS, Kim Y, Kroh EM, Chien JW, Eaton KD, Goodman MT, Tait JF, Tewari M, Pritchard CC.

PLoS One. 2013 Jun 7;8(6):e64795. doi: 10.1371/journal.pone.0064795. Print 2013.

29.

Building foundations for an open perspective on synthetic biology research and innovation.

Rant J, Tait J.

New Phytol. 2013 Oct;200(1):13-5. doi: 10.1111/nph.12361. Epub 2013 Jun 3. No abstract available.

30.

Unusual reversed wall motion pattern in a patient with recurrent takotsubo cardiomyopathy.

Tait J, Cleveland D, Ashton T.

Can J Cardiol. 2013 Aug;29(8):1015.e13-4. doi: 10.1016/j.cjca.2012.12.007. Epub 2013 Feb 8. No abstract available.

PMID:
23395218
31.

ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.

Pritchard CC, Smith C, Salipante SJ, Lee MK, Thornton AM, Nord AS, Gulden C, Kupfer SS, Swisher EM, Bennett RL, Novetsky AP, Jarvik GP, Olopade OI, Goodfellow PJ, King MC, Tait JF, Walsh T.

J Mol Diagn. 2012 Jul;14(4):357-66. doi: 10.1016/j.jmoldx.2012.03.002. Epub 2012 May 30.

32.

Adaptive governance of synthetic biology.

Tait J.

EMBO Rep. 2012 Jun 29;13(7):579. doi: 10.1038/embor.2012.76. No abstract available.

33.

Artificial microbes: Balanced regulation of synthetic biology.

Tait J, Castle D.

Nature. 2012 Apr 4;484(7392):37. doi: 10.1038/484037a. No abstract available.

PMID:
22481347
34.

Analysing stratified medicine business models and value systems: innovation-regulation interactions.

Mittra J, Tait J.

N Biotechnol. 2012 Sep 15;29(6):709-19. doi: 10.1016/j.nbt.2012.03.003. Epub 2012 Mar 13. Review.

PMID:
22440585
35.

Dangling conversations: reflections on the process of creating digital stories during a workshop with people with early-stage dementia.

Stenhouse R, Tait J, Hardy P, Sumner T.

J Psychiatr Ment Health Nurs. 2013 Mar;20(2):134-41. doi: 10.1111/j.1365-2850.2012.01900.x. Epub 2012 Mar 13.

PMID:
22413774
36.

Intravenous drug use: not a barrier to achieving a sustained virological response in HCV infection.

Jafferbhoy H, Miller MH, Dunbar JK, Tait J, McLeod S, Dillon JF.

J Viral Hepat. 2012 Feb;19(2):112-9. doi: 10.1111/j.1365-2893.2011.01446.x. Epub 2011 May 9.

PMID:
22239500
37.

Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies.

Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, Tait JF, Tewari M.

Cancer Prev Res (Phila). 2012 Mar;5(3):492-497. doi: 10.1158/1940-6207.CAPR-11-0370. Epub 2011 Dec 12.

38.

Global food security and the governance of modern biotechnologies.

Tait J, Barker G.

EMBO Rep. 2011 Jul 15;12(8):763-8. doi: 10.1038/embor.2011.135. No abstract available.

39.

Critical left main coronary artery stenosis identified by colour Doppler screening during pre-exercise stress echocardiogram.

Tait J, Ashton T.

Can J Cardiol. 2011 May-Jun;27(3):390.e13-4. doi: 10.1016/j.cjca.2010.12.055. No abstract available.

PMID:
21601777
40.

Ethics. Ethical framework for biofuels.

Buyx A, Tait J.

Science. 2011 Apr 29;332(6029):540-1. doi: 10.1126/science.1206064. Epub 2011 Apr 12. No abstract available.

PMID:
21487119
41.

A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer.

Chandler WL, Yeung W, Tait JF.

J Thromb Haemost. 2011 Jun;9(6):1216-24. doi: 10.1111/j.1538-7836.2011.04283.x.

42.

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma.

Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M.

Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5003-8. doi: 10.1073/pnas.1019055108. Epub 2011 Mar 7.

43.

Balancing open source stem cell science with commercialization.

Courtney A, de Sousa P, George C, Laurie G, Tait J.

Nat Biotechnol. 2011 Feb;29(2):115-6. doi: 10.1038/nbt.1773. No abstract available.

PMID:
21301432
44.

From maturity to value-added innovation: lessons from the pharmaceutical and agro-biotechnology industries.

Mittra J, Tait J, Wield D.

Trends Biotechnol. 2011 Mar;29(3):105-9. doi: 10.1016/j.tibtech.2010.11.004. Epub 2010 Dec 14.

PMID:
21163543
45.

COLD-PCR enhanced melting curve analysis improves diagnostic accuracy for KRAS mutations in colorectal carcinoma.

Pritchard CC, Akagi L, Reddy PL, Joseph L, Tait JF.

BMC Clin Pathol. 2010 Nov 26;10:6. doi: 10.1186/1472-6890-10-6.

46.

Annotation error of a common β°-thalassemia mutation (619 bp-deletion) has implications for molecular diagnosis.

Pritchard CC, Tait JF, Buller-Burckle AM, Mikula M.

Am J Hematol. 2010 Dec;85(12):978. doi: 10.1002/ajh.21875. No abstract available.

47.

Audit of severe acute maternal morbidity describing reasons for transfer and potential preventability of admissions to ICU.

Lawton BA, Wilson LF, Dinsdale RA, Rose SB, Brown SA, Tait J, Coles CL, McCaw A.

Aust N Z J Obstet Gynaecol. 2010 Aug;50(4):346-51. doi: 10.1111/j.1479-828X.2010.01200.x.

PMID:
20716262
48.

Characterization of a recombinant form of annexin VI for detection of apoptosis.

Smith C, Mehta R, Gibson DF, Levashova Z, Blankenberg FG, Tait JF.

Bioconjug Chem. 2010 Aug 18;21(8):1554-8. doi: 10.1021/bc100239k.

PMID:
20672837
49.

The impact of a managed care network on attendance, follow-up and treatment at a hepatitis C specialist centre.

Tait JM, McIntyre PG, McLeod S, Nathwani D, Dillon JF.

J Viral Hepat. 2010 Oct;17(10):698-704. doi: 10.1111/j.1365-2893.2009.01227.x.

PMID:
20002561
50.

Supplemental Content

Support Center